Benefiting from biological products, Jinyu Group attained a YoY growth rate of 12.1% in net income in 2011H1

Search by Type

Report Charts News

Search by Company

Code Company name

Benefiting from biological products, Jinyu Group attained a YoY growth rate of 12.1% in net income in 2011H1

Date:2011-10-10 Source:hangmeihangmei Text Size:

From January to June in 2011, the operating revenue of Jinyu Group registered RMB 240 million, down 18.0% YoY, with net income reaching RMB 63.83 million, up 12.1% YoY. The growth of net income cou...

Welcome to our website. This service is open to member only.

Registration

Contact our customer service team
Tel: 86-10-82600828, 82600893
Fax: 86-10-82601570
Email: report@researchinchina.com

Related Reports

China Heparin Industry Report, 2010-20112011-09-28
China Blood Products Industry Report, 2010-20112011-09-05
China Monoclonal Antibody Industry Report, 2010-20112011-07-05
China Insulin Industry Report, 20102011-01-25
China Heparin Industry Report, 20102010-12-18
China Blood Products Industry Report, 20102010-11-10
Global and China Biopharmaceutical Industry Report, 20102010-09-16
China Blood Products Industry Report, 20092009-10-13